MedTrace Logo

Hepatocellular Carcinoma and Rheumatoid Arthritis

NCT02880306 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 741379

Last updated 2016-08-26

No results posted yet for this study

Summary

Rheumatoid arthritis(RA) is a disorder with altered immunologic function and increased risk of developing malignancies, while studies examining the association between hepatocellular carcinoma (HCC) and RA remain lacking. The investigators aimed to investigate the risk of HCC between participants with and without RA.

Conditions

  • Carcinoma, Hepatocellular

Interventions

OTHER

RA

RA was diagnosed based on the 1987 American College of Rheumatology diagnostic criteria

Sponsors & Collaborators

  • Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-03-31
Completion
2016-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02880306 on ClinicalTrials.gov